CIGNA members: Please note that you may receive a letter in the mail stating that The Dermatology Center of Indiana is no longer in your network. This communication from CIGNA is incorrect and we would like to reassure you that we are still in network with CIGNA. We look forward to continuing to service you and your family for all your dermatology needs.

2013

Acne Vulgaris
Sponsor: Braintree Laboratories
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
12-45 Years
Phase: Phase 2
Start Date: February 2013
End Date: Date Here

Psoriasis
Sponsor: Maruho North America Inc.
Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis 18 Years and Older
Phase: Phase 3
Start Date: June 2013
End Date: April 2015

Plaque Psoriasis
Sponsor: Therapeutics, Inc.
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)
18 Years and Older
Phase: Phase 3
Start Date: June 2013
End Date: March 2014

Chronic Pruritus
Sponsor: Menlo Therapeutics Inc.
VPD-737 for Treatment of Chronic Pruritus
18-65 Years
Phase: Phase 2
Start Date: October 2013
End Date: April 2015

Atopic Dermatitis
Sponsor: Regeneron Pharmaceuticals | Sanofi
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis 18 Years and Older
Phase: Phase 3
Start Date: October 2013
End Date: December 2018

Acne Vulgaris
Sponsor: Cadila Healthcare Limited
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
12-40 Years
Phase: Phase 3
Start Date: November 2013
End Date: September 2016

Psoriasis
Sponsor: Promius Pharma, LLC
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
18 Years and Older
Phase: Phase 3
Start Date: November 2013
End Date: January 2015

Plaque Type Psoriasis
Sponsor: Sandoz | Hexal AG
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira
18 Years and Older
Phase: Phase 3
Start Date: December 2013
End Date: February 2016